Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:KNE)

Kane Biotech to Host Investor Webinar

GlobeNewswire 3 days ago

Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

GlobeNewswire 4 days ago

Kane Biotech to sell its STEM Animal Health for C$11.5 million

Jocelyn Aspa 7 days ago

Canadian Investment Regulatory Organization Trade Resumption - KNE

Canada NewsWire 8 days ago

Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health

GlobeNewswire 8 days ago

Canadian Investment Regulatory Organization Trading Halt - KNE

Canada NewsWire 8 days ago

Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 26, 2024

Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health

GlobeNewswire March 20, 2024

Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 - Conference Call to Follow

GlobeNewswire March 19, 2024
View More News ››

Opinion & Analysis (TSXV:KNE)

Emerging opportunity in a growing, high-value dermatological market

Ryan Dhillon 8 days ago

Big Copper Fox Metals’ (V.CUU) shareholders under water?

Stockhouse Editorial September 17, 2014

John Kaiser: ‘The bull is back,’ Stockhouse poster says

Stockhouse Editorial February 5, 2014
View More Opinion ››

Bullboard Posts (TSXV:KNE)

RE:Kane Biotech to Host Investor Webinar

These volumes haven't been seen for a while and cannot be ignored and I see it as a positive sign. I like to think it as some one...
MirrorWorldMan - 1 day ago

Kane Biotech to Host Investor Webinar

WINNIPEG, Manitoba, April 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane”) announces that it will be...
Betteryear2 - 2 days ago

RE:RE:RE:RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

1.71 M shares traded @ .12 at open today is interesting timing.  
MirrorWorldMan - 3 days ago

RE:RE:RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

Right.  Thank you for that.  
MirrorWorldMan - 3 days ago

RE:RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

No dilution, STEM was a Kane's subsidiary so  Dechra  bought 100% of STEM's shares 1/3 from Ecuphar NV (Animalcare) and...
RoyMax123 - 3 days ago

RE:New Press Release - Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

Did this transaction result in dilution and a loss of STEM in order to get proceeds.?. here is why I ask, "The Transaction was...
MirrorWorldMan - 4 days ago
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »